Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication
/PRNewswire/ -- Long Grove Pharmaceuticals announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation from Nevakar...
Sriram Ramanathan Peter Karas Capstone Development Services Nevakar Injectables Inc Long Grove Pharmaceuticals Prnewswire Long Grove Pharmaceuticals
Source: prnewswire.com